Xspray Pharma AB (publ) (STO:XSPRAY)
32.45
+0.20 (0.62%)
At close: Dec 5, 2025
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 1.35 billion as of December 5, 2025. Its market cap has decreased by -2.74% in one year.
Market Cap
1.35B
Enterprise Value
1.18B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.45
Market Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 1.35B, an increase of 260.53%. That is a compound annual growth rate of 16.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.35B | -12.01% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | 3.67B | 162.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 118.08B |
| Getinge AB | 57.52B |
| Sectra AB | 52.91B |
| Camurus AB | 35.99B |
| Asker Healthcare Group AB | 34.94B |
| Medicover AB | 34.29B |
| BioArctic AB | 27.25B |
| AddLife AB | 21.90B |